These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10463378)

  • 21. A qualitative analysis of gabapentin misuse and diversion among people who use drugs in Appalachian Kentucky.
    Vickers Smith R; Boland EM; Young AM; Lofwall MR; Quiroz A; Staton M; Havens JR
    Psychol Addict Behav; 2018 Feb; 32(1):115-121. PubMed ID: 29239621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gabapentin misuse, abuse and diversion: a systematic review.
    Smith RV; Havens JR; Walsh SL
    Addiction; 2016 Jul; 111(7):1160-74. PubMed ID: 27265421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gabapentin Therapy in Psychiatric Disorders: A Systematic Review.
    Berlin RK; Butler PM; Perloff MD
    Prim Care Companion CNS Disord; 2015; 17(5):. PubMed ID: 26835178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticonvulsants for the treatment of alcohol withdrawal syndrome and alcohol use disorders.
    Hammond CJ; Niciu MJ; Drew S; Arias AJ
    CNS Drugs; 2015 Apr; 29(4):293-311. PubMed ID: 25895020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined pharmacotherapies for the management of alcoholism: rationale and evidence to date.
    Lee MR; Leggio L
    CNS Drugs; 2014 Feb; 28(2):107-19. PubMed ID: 24497006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics.
    Schacht JP; Anton RF; Randall PK; Li X; Henderson S; Myrick H
    Psychopharmacology (Berl); 2013 Jun; 227(4):627-37. PubMed ID: 23389755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation.
    Addolorato G; Leggio L; Hopf FW; Diana M; Bonci A
    Neuropsychopharmacology; 2012 Jan; 37(1):163-77. PubMed ID: 22030714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregabalin reduces alcohol drinking and relapse to alcohol seeking in the rat.
    Stopponi S; Somaini L; Cippitelli A; de Guglielmo G; Kallupi M; Cannella N; Gerra G; Massi M; Ciccocioppo R
    Psychopharmacology (Berl); 2012 Mar; 220(1):87-96. PubMed ID: 21887495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurocognitive performance, alcohol withdrawal, and effects of a combination of flumazenil and gabapentin in alcohol dependence.
    Schacht JP; Randall PK; Waid LR; Baros AM; Latham PK; Wright TM; Myrick H; Anton RF
    Alcohol Clin Exp Res; 2011 Nov; 35(11):2030-8. PubMed ID: 21631542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutamatergic medications for the treatment of drug and behavioral addictions.
    Olive MF; Cleva RM; Kalivas PW; Malcolm RJ
    Pharmacol Biochem Behav; 2012 Feb; 100(4):801-10. PubMed ID: 21536062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gabapentin combined with naltrexone for the treatment of alcohol dependence.
    Anton RF; Myrick H; Wright TM; Latham PK; Baros AM; Waid LR; Randall PK
    Am J Psychiatry; 2011 Jul; 168(7):709-17. PubMed ID: 21454917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alcohol withdrawal kindling: is there a role for anticonvulsants?
    Modesto-Lowe V; Huard J; Conrad C
    Psychiatry (Edgmont); 2005 May; 2(5):25-31. PubMed ID: 21152146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular and behavioral interactions of gabapentin with alcohol dependence.
    Roberto M; Gilpin NW; O'Dell LE; Cruz MT; Morse AC; Siggins GR; Koob GF
    J Neurosci; 2008 May; 28(22):5762-71. PubMed ID: 18509038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutamatergic substrates of drug addiction and alcoholism.
    Gass JT; Olive MF
    Biochem Pharmacol; 2008 Jan; 75(1):218-65. PubMed ID: 17706608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on the neurobiology of alcohol withdrawal seizures.
    Rogawski MA
    Epilepsy Curr; 2005; 5(6):225-30. PubMed ID: 16372057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function.
    Johnson BA
    CNS Drugs; 2005; 19(10):873-96. PubMed ID: 16185095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in the pharmacotherapy of alcoholism.
    Myrick H; Anton R
    Curr Psychiatry Rep; 2004 Oct; 6(5):332-8. PubMed ID: 15355755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychiatric Uses of Newer Anticonvulsants.
    Berigan TR
    Prim Care Companion J Clin Psychiatry; 2001 Apr; 3(2):82-84. PubMed ID: 15014621
    [No Abstract]   [Full Text] [Related]  

  • 39. Open pilot study of gabapentin versus trazodone to treat insomnia in alcoholic outpatients.
    Karam-Hage M; Brower KJ
    Psychiatry Clin Neurosci; 2003 Oct; 57(5):542-4. PubMed ID: 12950711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of alcohol withdrawal syndrome with gabapentin.
    Bonnet U; Banger M; Leweke FM; Maschke M; Kowalski T; Gastpar M
    Pharmacopsychiatry; 1999 May; 32(3):107-9. PubMed ID: 10463378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.